Literature DB >> 21763088

Cannabinoids in oral fluid following passive exposure to marijuana smoke.

Christine Moore1, Cynthia Coulter, Donald Uges, James Tuyay, Susanne van der Linde, Arthur van Leeuwen, Margaux Garnier, Jonathan Orbita.   

Abstract

The concentration of tetrahydrocannabinol (THC) and its main metabolite 11-nor-Δ(9)-tetrahydrocannabinol-9-carboxylic acid (THC-COOH) as well as cannabinol (CBN), and cannabidiol (CBD) were measured in oral fluid following realistic exposure to marijuana in a Dutch coffee-shop. Ten healthy subjects, who were not marijuana smokers, volunteered to spend 3h in two different coffee shops in Groningen, The Netherlands. Subjects gave two oral fluid specimens at each time point: before entering the store, after 20 min, 40 min, 1h, 2h, and 3h of exposure. The specimens were collected outside the shop. Volunteers left the shop completely after 3h and also provided specimens approximately 12-22 h after beginning the exposure. The oral fluid specimens were subjected to immunoassay screening; confirmation for THC, cannabinol and cannabidiol using GC/MS; and THC-COOH using two-dimensional GC-GC/MS. THC was detectable in all oral fluid specimens taken 3h after exposure to smoke from recreationally used marijuana. In 50% of the volunteers, the concentration at the 3h time-point exceeded 4 ng/mL of THC, which is the current recommended cut-off concentration for immunoassay screening; the concentration of THC in 70% of the oral fluid specimens exceeded 2 ng/mL, currently proposed as the confirmatory cut-off concentration. THC-COOH was not detected in any specimens from passively exposed individuals. Therefore it is recommended that in order to avoid false positive oral fluid results assigned to marijuana use, by analyzing for only THC, the metabolite THC-COOH should also be monitored.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763088     DOI: 10.1016/j.forsciint.2011.06.019

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  22 in total

1.  Cannabinoid disposition in oral fluid after controlled smoked cannabis.

Authors:  Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-01-24       Impact factor: 8.327

2.  Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.

Authors:  Garry Milman; David M Schwope; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chim Acta       Date:  2012-01-20       Impact factor: 3.786

3.  Cannabinoid stability in authentic oral fluid after controlled cannabis smoking.

Authors:  Dayong Lee; Garry Milman; David M Schwope; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-04-24       Impact factor: 8.327

4.  Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.

Authors:  Sebastien Anizan; Garry Milman; Nathalie Desrosiers; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-08-17       Impact factor: 4.142

5.  Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Authors:  Sarah K Himes; Karl B Scheidweiler; Olof Beck; David A Gorelick; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-09-17       Impact factor: 8.327

6.  Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers.

Authors:  Matthew N Newmeyer; Nathalie A Desrosiers; Dayong Lee; Damodara R Mendu; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-03-20       Impact factor: 3.345

7.  Impact of oral fluid collection device on cannabinoid stability following smoked cannabis.

Authors:  Sébastien Anizan; Mateus M Bergamaschi; Allan J Barnes; Garry Milman; Nathalie Desrosiers; Dayong Lee; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2014-07-03       Impact factor: 3.345

8.  Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-08-10       Impact factor: 3.345

9.  11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Sarah K Himes; Xiaohong Chen; Hua-Fen Liu; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-05-17       Impact factor: 4.142

10.  On-site test for cannabinoids in oral fluid.

Authors:  Nathalie A Desrosiers; Dayong Lee; David M Schwope; Garry Milman; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-08-21       Impact factor: 8.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.